Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.14 - $12.49 $1,413 - $126,061
-10,093 Reduced 3.55%
273,907 $41,000
Q3 2022

Nov 14, 2022

SELL
$8.51 - $13.6 $72,666 - $116,130
-8,539 Reduced 2.92%
284,000 $2.98 Million
Q2 2022

Aug 12, 2022

BUY
$7.31 - $11.85 $1.71 Million - $2.77 Million
234,114 Added 400.71%
292,539 $2.83 Million
Q1 2022

May 13, 2022

BUY
$7.35 - $10.63 $3,270 - $4,730
445 Added 0.77%
58,425 $480,000
Q4 2021

Feb 08, 2022

SELL
$4.19 - $9.56 $2,664 - $6,080
-636 Reduced 1.09%
57,980 $554,000
Q3 2021

Nov 15, 2021

SELL
$3.56 - $4.64 $25,162 - $32,795
-7,068 Reduced 10.76%
58,616 $272,000
Q2 2021

Aug 13, 2021

SELL
$3.95 - $5.41 $995,076 - $1.36 Million
-251,918 Reduced 79.32%
65,684 $284,000
Q1 2021

May 12, 2021

SELL
$4.52 - $7.8 $83,565 - $144,206
-18,488 Reduced 5.5%
317,602 $1.68 Million
Q4 2020

Feb 11, 2021

SELL
$4.37 - $9.46 $34,789 - $75,311
-7,961 Reduced 2.31%
336,090 $2.37 Million
Q3 2020

Nov 16, 2020

SELL
$8.56 - $26.93 $107,042 - $336,759
-12,505 Reduced 3.51%
344,051 $3.12 Million
Q2 2020

Aug 14, 2020

BUY
$21.21 - $31.55 $1.53 Million - $2.28 Million
72,320 Added 25.44%
356,556 $9.8 Million
Q1 2020

May 14, 2020

BUY
$18.43 - $38.04 $79,507 - $164,104
4,314 Added 1.54%
284,236 $6.25 Million
Q4 2019

Feb 14, 2020

SELL
$29.6 - $43.71 $212,794 - $314,231
-7,189 Reduced 2.5%
279,922 $10.6 Million
Q3 2019

Nov 13, 2019

BUY
$29.87 - $42.22 $1.22 Million - $1.72 Million
40,792 Added 16.56%
287,111 $8.86 Million
Q2 2019

Aug 13, 2019

BUY
$31.16 - $39.46 $883,043 - $1.12 Million
28,339 Added 13.0%
246,319 $9.72 Million
Q1 2019

May 13, 2019

BUY
$19.96 - $38.62 $1.14 Million - $2.2 Million
57,017 Added 35.42%
217,980 $8.42 Million
Q4 2018

Feb 12, 2019

BUY
$23.57 - $32.33 $313,080 - $429,439
13,283 Added 8.99%
160,963 $3.8 Million
Q3 2018

Nov 14, 2018

BUY
$22.5 - $39.35 $2.99 Million - $5.22 Million
132,707 Added 886.31%
147,680 $4.51 Million
Q2 2018

Sep 18, 2018

BUY
$26.0 - $29.9 $389,298 - $447,692
14,973 New
14,973 $448,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.